trending Market Intelligence /marketintelligence/en/news-insights/trending/CMbVga7k74MzHOxc18W2PA2 content esgSubNav
In This List

TrovaGene director to resign

Blog

Insight Weekly: Ukraine war impact on mining; US bank growth slowdown; cloud computing headwinds

Blog

Insight Weekly: Cryptocurrency's growth; green bond market outlook; coal investors' windfall

Blog

Global M&A By the Numbers: Q1 2022

Blog

Insight Weekly: Challenges for European banks; Japan's IPO slowdown; carmakers' supply woes


TrovaGene director to resign

TrovaGene Inc. said that Stanley Tennant will resign as a director, effective Dec. 31.

Tennant's resignation is due to personal reasons and not a result of any disagreement with the company, its management or board, TrovaGene said in a Dec. 10 regulatory document.

San Diego-based Trovagene is a clinical-stage biopharmaceutical company focused on developing oncology therapeutics.